Literature DB >> 17582759

Comparison of estrogen-derived ortho-quinone and para-quinol concerning induction of oxidative stress.

Nilka M Rivera-Portalatin1, José L Vera-Serrano, Katalin Prokai-Tatrai, Laszlo Prokai.   

Abstract

Ortho-quinones formed from catechol estrogens are considered prooxidants due to the production of superoxide radical anions through redox cycling via semiquinones. Para-quinols have been identified as novel metabolites of and as the major products of hydroxyl-radical scavenging by estrogens. Cycling of these compounds has also been discovered, because they are converted back to the parent estrogen via reductive aromatization in vitro and in vivo. We hypothesized that, unlike ortho-quinones, para-quinols do not induce oxidative stress due to this cycling. Like the estrogen itself, the 17beta-estradiol-derived para-quinol (10beta,17beta-dihydroxyestra-1,4-diene-3-one) did not induce oxidative stress, as the rate of hydrogen peroxide production during the incubations of the compounds in various tissue homogenates was not significantly different from that of the control experiments performed without the addition of a test compound. We also confirmed that the estrogen metabolite estra-1,5(10)-dien-3,4,17-trione (estrone 3,4-quinone) was a profound prooxidant due to redox cycling, especially in uterine tissue. Therefore, we concluded that para-quinols do not induce oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582759      PMCID: PMC2752863          DOI: 10.1016/j.jsbmb.2006.11.025

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  35 in total

Review 1.  Oestrogen as a neuroprotective hormone.

Authors:  Christian Behl
Journal:  Nat Rev Neurosci       Date:  2002-06       Impact factor: 34.870

2.  Estradiol exerts neuroprotective effects when administered after ischemic insult.

Authors:  S H Yang; J Shi; A L Day; J W Simpkins
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

3.  Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene.

Authors:  D Chakravarti; P C Mailander; K M Li; S Higginbotham; H L Zhang; M L Gross; J L Meza; E L Cavalieri; E G Rogan
Journal:  Oncogene       Date:  2001-11-29       Impact factor: 9.867

Review 4.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Synthesis and biological evaluation of 17beta-alkoxyestra-1,3, 5(10)-trienes as potential neuroprotectants against oxidative stress.

Authors:  L Prokai; S M Oon; K Prokai-Tatrai; K A Abboud; J W Simpkins
Journal:  J Med Chem       Date:  2001-01-04       Impact factor: 7.446

Review 6.  Role of quinones in toxicology.

Authors:  J L Bolton; M A Trush; T M Penning; G Dryhurst; T J Monks
Journal:  Chem Res Toxicol       Date:  2000-03       Impact factor: 3.739

Review 7.  Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens.

Authors:  Judy L Bolton
Journal:  Toxicology       Date:  2002-08-01       Impact factor: 4.221

8.  Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis.

Authors:  Ran Liu; Shao-Hua Yang; Evelyn Perez; Kun Don Yi; Samuel S Wu; Kathleen Eberst; Laszlo Prokai; Katalin Prokai-Tatrai; Zu Yun Cai; Douglas F Covey; Arthur L Day; James W Simpkins
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

9.  Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases.

Authors:  Ercole L Cavalieri; Kai-Ming Li; Narayanan Balu; Muhammad Saeed; Prabu Devanesan; Sheila Higginbotham; John Zhao; Michael L Gross; Eleanor G Rogan
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

10.  Influence of estradiol and gestagens on oxidative stress in the rat uterus.

Authors:  M A Gómez-Zubeldia; S Corrales; J Arbués; A G Nogales; J C Millán
Journal:  Gynecol Oncol       Date:  2002-09       Impact factor: 5.482

View more
  5 in total

1.  Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells.

Authors:  Yi-Hua Jan; Diane E Heck; Joshua P Gray; Haiyan Zheng; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

2.  The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.

Authors:  Laszlo Prokai; Vien Nguyen; Szabolcs Szarka; Puja Garg; Gauri Sabnis; Heather A Bimonte-Nelson; Katie J McLaughlin; Joshua S Talboom; Cheryl D Conrad; Paul J Shughrue; Todd D Gould; Angela Brodie; Istvan Merchenthaler; Peter Koulen; Katalin Prokai-Tatrai
Journal:  Sci Transl Med       Date:  2015-07-22       Impact factor: 17.956

3.  Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative.

Authors:  Katalin Prokai-Tatrai; Pal Perjesi; Nilka M Rivera-Portalatin; James W Simpkins; Laszlo Prokai
Journal:  Steroids       Date:  2007-11-04       Impact factor: 2.668

Review 4.  Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents.

Authors:  Israel Pérez-Torres; Verónica Guarner-Lans; María Esther Rubio-Ruiz
Journal:  Int J Mol Sci       Date:  2017-10-05       Impact factor: 5.923

Review 5.  A Novel Prodrug Approach for Central Nervous System-Selective Estrogen Therapy.

Authors:  Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.